Truist Financial Lowers HCA Healthcare (NYSE:HCA) Price Target to $390.00

HCA Healthcare (NYSE:HCA) had its target price decreased by investment analysts at Truist Financial from $430.00 to $390.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s price objective would suggest a potential upside of 26.40% from the company’s current price.

HCA has been the subject of a number of other research reports. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. KeyCorp decreased their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Finally, Oppenheimer increased their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $385.27.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $308.55 on Monday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a 50-day simple moving average of $324.68 and a 200 day simple moving average of $354.48. HCA Healthcare has a fifty-two week low of $276.50 and a fifty-two week high of $417.14. The company has a market cap of $78.15 billion, a PE ratio of 13.85, a P/E/G ratio of 1.21 and a beta of 1.64.

Insider Activity

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On HCA Healthcare

Hedge funds have recently modified their holdings of the stock. Savant Capital LLC lifted its holdings in shares of HCA Healthcare by 68.6% during the 2nd quarter. Savant Capital LLC now owns 3,454 shares of the company’s stock valued at $1,110,000 after buying an additional 1,405 shares during the last quarter. Great Lakes Advisors LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at $7,790,000. Acadian Asset Management LLC boosted its holdings in HCA Healthcare by 108.2% in the second quarter. Acadian Asset Management LLC now owns 7,021 shares of the company’s stock worth $2,253,000 after purchasing an additional 3,649 shares in the last quarter. Koss Olinger Consulting LLC bought a new position in HCA Healthcare during the second quarter valued at about $303,000. Finally, Ballentine Partners LLC increased its holdings in shares of HCA Healthcare by 3.3% during the 2nd quarter. Ballentine Partners LLC now owns 4,006 shares of the company’s stock valued at $1,287,000 after acquiring an additional 127 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.